A recent study explores how combining cognitive behavioral therapy for insomnia with pain management could impact outcomes for patients with chronic spinal pain and insomnia.
A new randomized trial evaluates the impact of integrating pain education into standard physiotherapy care for chronic low back pain, highlighting potential benefits for pain, disability, and well-being. ...
Results from a recent randomized controlled trial shows that cognitive-behavioral stress management (CBSM) significantly reduces anxiety, depression, and post-traumatic stress disorder in parents of...
A phase 3 clinical trial demonstrates the efficacy of olezarsen in reducing plasma triglycerides and acute pancreatitis episodes in patients with familial chylomicronemia syndrome.
A recent study assessed cervical cancer mortality trends among US women younger than 25 from 1992 to 2021, highlighting changes in mortality rates following the widespread use of the HPV vaccine.
Acoramidis, an oral therapy, is now approved to reduce cardiovascular-related deaths and hospitalizations in adults with hereditary or wild-type ATTR-CM.
Researchers developed a cross-sectional survey to understand the public and provider awareness of postmenopausal bleeding as a symptom of endometrial cancer.
A decade-long follow-up of a landmark trial examining survival outcomes in patients with advanced melanoma treated with nivolumab plus ipilimumab, nivolumab monotherapy, or ipilimumab monotherapy, provides...
A recent phase 3 study found that venetoclax-obinutuzumab improves progression-free survival and quality of life compared with chlorambucil-obinutuzumab in patients with untreated chronic lymphocytic...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
